(Q44170173)

English

Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS.

scientific article published in October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jingduan Chi

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Anura L Jayewardene

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Judith A Stone

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Toshiro Motoya

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Francesca T Aweeka

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Journal of Pharmaceutical and Biomedical Analysis

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

675-684

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

describes a project that uses

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Current knowledge and future prospects for the use of HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of ritonavir, a new HIV protease inhibitor, in biological samples using reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of saquinavir in human plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of indinavir in plasma by solid-phase extraction and column liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid quantification of indinavir in human plasma by high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Simple high-performance liquid chromatographic determination of the protease inhibitor indinavir in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of L-756 423, a novel HIV protease inhibitor, in human plasma and urine using high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative determination of CGP 61755, a protease inhibitor, in plasma and urine by high-performance liquid chromatography and fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

LC determination of indinavir in biological matrices with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of indinavir, a HIV-1 protease inhibitor, in human plasma using ion-pair reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and saliva.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of indinavir in human cerebrospinal fluid and plasma by solid-phase extraction and high-performance liquid chromatography with column switching

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromatographic and immunochemical approaches to the analysis of the HIV protease inhibitor saquinavir in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensitive liquid chromatographic assay for amprenavir, a human immunodeficiency virus protease inhibitor, in human plasma, cerebrospinal fluid and semen

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Liquid chromatographic-tandem mass spectrometric determination of amprenavir (agenerase) in serum/plasma of human immunodeficiency virus type-1 infected patients receiving combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous determination of ritonavir and saquinavir, two human immunodeficiency virus protease inhibitors, in human serum by high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous determination of unlabeled and deuterium-labeled indinavir in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High-performance liquid chromatographic method for the simultaneous determination of HIV-1 protease inhibitors indinavir, saquinavir and ritonavir in plasma of patients during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900357-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0731-7085(02)00357-6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44170173&oldid=2144372409"